Faruqi and Faruqui, LLP Logo
Share this page

Endo International PLC (ENDP)

NASDAQ:ENDP

Summary

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Endo International PLC To Contact The Firm Before Lead Plaintiff Deadline

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Endo International PLC (“Endo” or the “Company”) (NASDAQ:ENDP) of the January 3, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.

The lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased Endo stock or options between February 25, 2014 and November 3, 2016 (the “Class Period”).  The case, Shasha v. Endo International PLC et al, No. 16-cv-08645 was filed on November 7, 2016.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to disclose that one of its subsidiaries had engaged in potential pricing collusion activities that would prompt a Department of Justice (“DOJ”) antitrust investigation that could lead to potential criminal charges against the Company. 

On September 28, 2015, Endo announced that it had completed its $8.05 billion acquisition of Par Pharmaceutical Holdings, Inc. (“Par Pharmaceutical”) from the private investment firm TPG.  Then, on November 3, 2016, Bloomberg published the article titled “U.S. Charges in Generic-Drug Probe to Be Filed by Year End” which discussed the DOJ’s two year investigation of suspected price collusion by several pharmaceutical companies, including Par Pharmaceutical. 

After the announcement, KLX’s share price fell from $18.17 per share on November 2, 2016 to a closing price of $14.63 on November 3, 2016—a $3.54 or a 19.5% drop.

Take Action

If you invested in Endo stock or options between February 25, 2014 and November 3, 2016  and would like to discuss your legal rights, please fill out the form below. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Endo’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Request Information

Please tell us about yourself by completing the form and we will provide you with additional
information on how to join the Class Action at no cost to you.

  • Case:
    Endo International PLC (ENDP)
  •    

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330

Email:

Case Details

Date:

  • 11/08/2016

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.